Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zomedica Pharmaceuticals (ZOM)
NYSE MKT:ZOM
Holding ZOM?
Track your performance easily
ZOM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.12 - $0.23
Previous Close$0.15
Volume3.21M
Average Volume (3M)5.26M
Market Cap
$149.05M
Enterprise Value$61.28M
Total Cash (Recent Filing)$90.50M
Total Debt (Recent Filing)$2.73M
Price to Earnings (P/E)―
Beta1.71
Next Earnings
Aug 08, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding979,949,668
10 Day Avg. Volume3,549,099
30 Day Avg. Volume5,255,108
Standard Deviation0.48
R-Squared0.00916
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)0.61
Price to Sales (P/S)19.49
Price to Cash Flow (P/CF)-7.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.43
Enterprise Value/Gross Profit3.54
Enterprise Value/Ebitda-2.04
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Zomedica Pharmaceuticals News
PremiumCompany Announcements
Zomedica’s Revenue Up 10% Amid Global Expansion
PremiumCompany Announcements
Zomedica Corp Posts Increased Revenue Amid Loss
PremiumCompany Announcements
Zomedica Achieves Record Revenue and Steady Growth in 2023
Ownership Overview
11.44% Insiders
5.90% Mutual Funds
4.78% Other Institutional Investors
77.88% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ZOM FAQ
What was Zomedica Pharmaceuticals’s price range in the past 12 months?
Zomedica Pharmaceuticals lowest stock price was $0.12 and its highest was $0.23 in the past 12 months.
What is Zomedica Pharmaceuticals’s market cap?
Currently, no data Available
When is Zomedica Pharmaceuticals’s upcoming earnings report date?
Zomedica Pharmaceuticals’s upcoming earnings report date is Aug 08, 2024 which is 105 days ago.
How were Zomedica Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Zomedica Pharmaceuticals overvalued?
According to Wall Street analysts Zomedica Pharmaceuticals’s price is currently Overvalued.
Does Zomedica Pharmaceuticals pay dividends?
Zomedica Pharmaceuticals does not currently pay dividends.
What is Zomedica Pharmaceuticals’s EPS estimate?
Zomedica Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zomedica Pharmaceuticals have?
Zomedica Pharmaceuticals has 979,949,650 shares outstanding.
What happened to Zomedica Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Zomedica Pharmaceuticals?
Among the largest hedge funds holding Zomedica Pharmaceuticals’s share is Invst, LLC. It holds Zomedica Pharmaceuticals’s shares valued at 10K.
---
Zomedica Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ZOM Sentiment 80%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $229.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 2.1%
Last 30 Days ▲ 2.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.19%
12-Months-Change
Fundamentals
Return on Equity
-15.07%
Trailing 12-Months
Asset Growth
-12.84%
Trailing 12-Months
Company Description
Zomedica Pharmaceuticals
Zomedica Pharmaceuticals Corp. operates as a development stage veterinary diagnostic and pharmaceutical company. It creates products for companion animals by focusing on the unmet needs of clinical veterinarians. The company was founded by Gerald L. Solensky, Jr. on January 7, 2013 and is headquartered in Ann Arbor, MI.
---
ZOM Earnings Call
Q1 2024
0:00 / 0:00
---
ZOM Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---